• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠肝循环药物的药代动力学模拟及曲线下面积估计

Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.

作者信息

Alpízar Melchor, de Jesús Reséndiz José, García Martínez Elisa, Dwivedi Sanyog, Trejo Miguel Alejandro

机构信息

Specialized Centre for Diabetes, Obesity and Prevention of Cardiovascular Diseases (CEDOPEC) & Bioequivalence Studies (E-BIOS-CEDOPEC), Mexico City 11650, Mexico.

出版信息

Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044.

DOI:10.3390/pharmaceutics16081044
PMID:39204389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11360071/
Abstract

Enterohepatic circulation (EHC) is a complex process where drugs undergo secretion and reabsorption from the intestinal lumen multiple times, resulting in pharmacokinetic profiles with multiple peaks. The impact of EHC on area under the curve (AUC) has been a topic of extensive debate, questioning the suitability of conventional AUC estimation methods. Moreover, a universal model for accurately estimating AUC in EHC scenarios is lacking. To address this gap, we conducted a simulation study evaluating five empirical models under various sampling strategies to assess their performance in AUC estimation. Our results identify the most suitable model for EHC scenarios and underscore the critical role of meal-based sampling strategies in accurate AUC estimation. Additionally, we demonstrate that while the trapezoidal method performs comparably to other models with a large number of samples, alternative models are essential when sample numbers are limited. These findings not only illuminate how EHC influences AUC but also pave the way for the application of empirical models in real-world drug studies.

摘要

肠肝循环(EHC)是一个复杂的过程,在此过程中药物多次经历从肠腔的分泌和重吸收,导致药代动力学曲线出现多个峰值。肠肝循环对曲线下面积(AUC)的影响一直是广泛争论的话题,这对传统AUC估计方法的适用性提出了质疑。此外,缺乏一种在肠肝循环情况下准确估计AUC的通用模型。为了填补这一空白,我们进行了一项模拟研究,评估了在各种采样策略下的五个经验模型,以评估它们在AUC估计中的性能。我们的结果确定了最适合肠肝循环情况的模型,并强调了基于进餐的采样策略在准确AUC估计中的关键作用。此外,我们证明,虽然梯形法在样本数量较多时与其他模型表现相当,但当样本数量有限时,替代模型至关重要。这些发现不仅阐明了肠肝循环如何影响AUC,也为经验模型在实际药物研究中的应用铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/81dc846232a2/pharmaceutics-16-01044-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/22cf3dbe162b/pharmaceutics-16-01044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/52bba636881b/pharmaceutics-16-01044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/f24933359fa6/pharmaceutics-16-01044-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/8124bf8f2739/pharmaceutics-16-01044-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/b3b61bc59f48/pharmaceutics-16-01044-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/aacddd6a52ce/pharmaceutics-16-01044-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/73eb12d00d1e/pharmaceutics-16-01044-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/2eaca58a7d43/pharmaceutics-16-01044-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/81dc846232a2/pharmaceutics-16-01044-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/22cf3dbe162b/pharmaceutics-16-01044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/52bba636881b/pharmaceutics-16-01044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/f24933359fa6/pharmaceutics-16-01044-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/8124bf8f2739/pharmaceutics-16-01044-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/b3b61bc59f48/pharmaceutics-16-01044-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/aacddd6a52ce/pharmaceutics-16-01044-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/73eb12d00d1e/pharmaceutics-16-01044-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/2eaca58a7d43/pharmaceutics-16-01044-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f3/11360071/81dc846232a2/pharmaceutics-16-01044-g009.jpg

相似文献

1
Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.肠肝循环药物的药代动力学模拟及曲线下面积估计
Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044.
2
A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.一种用于药代动力学研究的基于胆囊的肠肝循环模型。
Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):493-504. doi: 10.1007/s13318-018-0535-1.
3
Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.受肠肝循环影响的甾体药物药代动力学模型系统。
Exp Clin Endocrinol. 1986 Jul;87(2):118-24. doi: 10.1055/s-0029-1210532.
4
Role of enterohepatic recirculation in drug disposition: cooperation and complications.肠肝循环在药物处置中的作用:合作与并发症。
Drug Metab Rev. 2016 May;48(2):281-327. doi: 10.3109/03602532.2016.1157600. Epub 2016 Mar 18.
5
A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.一种定量的肠肝循环模型:特索芬辛和美洛昔康的开发和评估。
Clin Pharmacokinet. 2009;48(8):529-42. doi: 10.2165/11313370-000000000-00000.
6
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.在接受环孢素或西罗莫司联合治疗的稳定肾移植患者中,霉酚酸曲线下面积预测的有限采样模型和贝叶斯估计
Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.
7
Noncompartmental area under the curve determinations for drugs that cycle in the bile.针对在胆汁中循环的药物的非房室曲线下面积测定。
Biopharm Drug Dispos. 1988 Sep-Oct;9(5):465-75. doi: 10.1002/bod.2510090505.
8
Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.中国健康人群中霉酚酸肠肝循环的群体药代动力学建模及尿苷二磷酸葡萄糖醛酸基转移酶1A9基因多态性的影响
Br J Clin Pharmacol. 2008 Jun;65(6):893-907. doi: 10.1111/j.1365-2125.2008.03109.x. Epub 2008 Feb 15.
9
Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration-Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia.甲磺酸伊马替尼的药代动力学和建立有限采样策略以估算巴勒斯坦慢性髓性白血病患者甲磺酸伊马替尼浓度-时间曲线下面积。
Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):43-55. doi: 10.1007/s13318-023-00868-y. Epub 2023 Nov 25.
10
The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease.从群体药代动力学模型的发展,看在实体器官移植和自身免疫性疾病中麦考酚酸的肠肝循环。
Clin Pharmacokinet. 2011 Jan;50(1):1-24. doi: 10.2165/11536640-000000000-00000.

引用本文的文献

1
Gallic acid: a dietary metabolite's therapeutic potential in the management of atherosclerotic cardiovascular disease.没食子酸:一种膳食代谢产物在动脉粥样硬化性心血管疾病管理中的治疗潜力。
Front Pharmacol. 2025 Jan 7;15:1515172. doi: 10.3389/fphar.2024.1515172. eCollection 2024.

本文引用的文献

1
Limited sampling strategy and population pharmacokinetic model of mycophenolic acid in pediatric patients with systemic lupus erythematosus: application of a double gamma absorption model with SAEM algorithm.系统性红斑狼疮患儿霉酚酸的有限采样策略及群体药代动力学模型:采用SAEM算法的双伽马吸收模型的应用
Eur J Clin Pharmacol. 2024 Jan;80(1):83-92. doi: 10.1007/s00228-023-03587-0. Epub 2023 Oct 28.
2
Effect of Meal Timings and Meal Content on the AUC of Mycophenolic Acid: A Simulation Study.饮食时间和饮食内容对麦考酚酸 AUC 的影响:一项模拟研究。
Clin Pharmacol Drug Dev. 2022 Nov;11(11):1331-1340. doi: 10.1002/cpdd.1141. Epub 2022 Aug 31.
3
Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery.
肠肝循环中的胆汁酸转运体用于靶向药物递送。
Molecules. 2022 May 5;27(9):2961. doi: 10.3390/molecules27092961.
4
Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug-Drug Interaction with Rifampin and Liver Impairment.卡博替尼的基于生理的药代动力学建模,以模拟肠肝循环、与利福平的药物相互作用及肝功能损害。
Pharmaceutics. 2021 May 22;13(6):778. doi: 10.3390/pharmaceutics13060778.
5
Enteric reabsorption processes and their impact on drug pharmacokinetics.肠内重吸收过程及其对药物药代动力学的影响。
Sci Rep. 2021 Mar 11;11(1):5794. doi: 10.1038/s41598-021-85174-w.
6
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder.盐酸哌甲酯多层缓释胶囊(Aptensio XR)在注意缺陷多动障碍学龄前儿童中的药代动力学研究。
Paediatr Drugs. 2020 Oct;22(5):561-570. doi: 10.1007/s40272-020-00409-z.
7
Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview.基于生理的药代动力学模型在临床药理学与治疗学中的应用:综述
Curr Pharmacol Rep. 2020;6(3):71-84. doi: 10.1007/s40495-020-00212-x. Epub 2020 May 12.
8
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings.在健康和病理条件下人类胆汁酸分布和代谢的基于生理学的模型。
Cell Mol Gastroenterol Hepatol. 2020;10(1):149-170. doi: 10.1016/j.jcmgh.2020.02.005. Epub 2020 Feb 26.
9
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.通过在健康受试者中进行的部分重复交叉研究,比较非马沙坦/氨氯地平60/10毫克固定剂量复方制剂与相应的松散组合制剂的药代动力学。
Transl Clin Pharmacol. 2019 Dec;27(4):134-140. doi: 10.12793/tcp.2019.27.4.134. Epub 2019 Dec 31.
10
Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.新型低剂量微粉化异维 A 酸 32 毫克制剂和利朵斯异维 A 酸 40 毫克在进食和禁食条件下的药代动力学比较:两项在健康成年参与者中进行的开放标签、随机、交叉研究。
Acta Derm Venereol. 2020 Feb 5;100(4):adv00049. doi: 10.2340/00015555-3381.